Substituted 8-heteroaryl xanthines

Details for Australian Patent Application No. 2004268964 (hide)

International Classifications

Event Publications

16 March 2006 PCT application entered the National Phase

PCT publication WO2005/021548 Priority application(s): WO2005/021548

4 June 2009 Assignment before Grant

Adenosine Therapeutics, LLC The application has been assigned to PGxHealth, LLC

11 March 2010 Application Accepted

Published as AU-B-2004268964

8 July 2010 Standard Patent Sealed

24 March 2011 Alteration of Name

The name of the patentee has been altered to Trovis Pharmaceuticals, LLC

16 August 2012 Assignment Registered

Trovis Pharmaceuticals, LLC The patent has been assigned to Dogwood Pharmaceuticals, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.